Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Bioreactive Technologies Inc. maintains a portfolio within the Chemistry & Materials technology area. The data indicates 1 pending office action is currently active. This specific action is being reviewed by a distinct examiner, which centralizes the prosecution effort. Furthermore, the case is situated in a distinct art unit, ensuring that the technical review is confined to a specialized group within the patent office.
The busiest examiner for the portfolio is HURST, JONATHAN M. This individual is currently managing 1 busiest examiner pending office action. Since the total count of pending matters is limited, the prosecution strategy does not need to account for different examiner personalities or varying art unit norms. The focus on Chemistry & Materials suggests the subject matter is consistent with the company's technical strengths.
A practitioner handling this portfolio deals with a concentrated workload. Because there is the current pending matter, the influence of the busiest examiner is significant over the docket. The alignment of the distinct art unit and the examiner provides a streamlined path for prosecution. This structure allows for a dedicated focus on the specific requirements of HURST, JONATHAN M to resolve the outstanding issues.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HURST, JONATHAN M | 1 | 53.5% | +19.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18203526 | APPARATUS AND METHODS FOR LIQUID CULTURE PRODUCTION AND INOCULATION | HURST, JONATHAN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18203526 | APPARATUS AND METHODS FOR LIQUID CULTURE PRODUCTION AND INOCULATION | HURST, JONATHAN M | — |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18203526 | APPARATUS AND METHODS FOR LIQUID CULTURE PRODUCTION AND INOCULATION | HURST, JONATHAN M | 1799 | §103§112 | Non-Final OA | — | Pending | May 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBioreactive Technologies Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jonathan M Hurst has the most, with 1 of Bioreactive Technologies Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
